Re: Completion of therapy by medicare patients with stage III colon cancer [1]

Journal of the National Cancer Institute

Volumn 98, Issue 21, 2006, Pages 1582-

  Gibbs, Peter ^a,b,c   McLaughlin, Stephen ^b   Skinner, Iain ^b   Jones, Ian ^a   Hayes, Ian ^a   Chapman, Matthew ^c   Johns, Julie ^c   Lim, Lionel ^a,b,c   Faragher, Ian ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b WESTERN HOSPITAL   (Australia)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

ADULT; AGE DISTRIBUTION; AGED; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CLINICAL TRIAL; COLON CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG INDICATION; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MEDICARE; ONSET AGE; PATIENT DECISION MAKING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COLONIC NEOPLASMS; DECISION MAKING; FRAIL ELDERLY; HUMANS; MEDICAL RECORD LINKAGE; MEDICARE; MIDDLE AGED; NEOPLASM STAGING; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SEER PROGRAM; UNITED STATES;

EID: 33750599653     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj416     Document Type: Letter

References (2)

1. Dobie SA, Baldwin LM, Dominitz JA, Matthews B, Billingsley K, Barlow W. Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst 2006;98:610-9.
2. Lembersky BC, Wieand HS, Petrelli NJ, O'Connell MJ, Colangelo LH, Smith RE, et al. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: Results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. J Clin Oncol 2006;24:2059-64.